Rapid Development of Spatial Signatures as Predictive Biomarkers for Immunotherapy Response
The emergence of new immunotherapies as the first line of treatment for cancer, necessitates the development of clinically useful biomarkers to identify patients who will benefit. Join this webinar to learn more about spatial signatures, biomarkers based on spatial relationships and protein co-expression on specific cellular subsets that are assessed within the context of the tumor immune microenvironment (TiME), which have demonstrated higher accuracy in predicting response to immunotherapies. Our speaker Alessio Colombo, Technical Applications Scientist will also discuss Akoya’s new multiplex panels based on novel protein chemistry that can accelerate the development of spatial signatures, simplifying the pathway to improved stratification to immunotherapy response.
Related Resources
